Disclosure under regulation 29(2) of SEBI(SAST) Regulations, 2011 received from Ishita Pharmaceuticals, related party of Ishita Drugs and Industries Limited.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Pharmaceuticals, a related party of Ishita Drugs & Industries Ltd, acquired 807 equity shares (face value Rs. 10) through open market purchase on November 17, 2025. This represents just 0.03% of the company's total share capital. The acquirer's holding in Ishita Drugs went from 25,353 shares (0.85%) to 26,160 shares (0.88%). Total equity share capital of the company remains Rs. 2,99,03,000 (29,90,300 shares of Rs. 10 each). The disclosure was filed under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
This is a very small, marginal purchase (807 shares, 0.03%) by a related party and is unlikely to have any meaningful impact on the stock price or shareholder value. It signals continued insider/related-party confidence in the company but the size is too small to materially affect ownership structure.